Skip to main content
. 2017 Apr 19;8(31):51264–51276. doi: 10.18632/oncotarget.17230

Figure 3. Engineered organoids derived from additional African American subjects AA-2, AA-3, and AA-4.

Figure 3

(A, C, and E) Organoid sizes (areas) of AA-2 (A), AA-3 (C), and AA-4 (E) at day 8. The areas (um2) of organoids >25 um diameter were measured by ImageJ. *p < 0.05, ***p < 0.001. (B, D, and F) Representative bright field and fluorescence images of MPPA (MYC, shPTEN, shTP53, and AR-transduced) and shCtrl organoids of AA-2 (B), AA-3 (D), and AA-4 (F) at day 8. Scale bars 300 um.